Accordingly, the use of Anginex (a 33 amino acid galectin-1 inhibitory peptide) combined with a suboptimal dose of radiation causes tumor regression in ovarian, mammary, and squamous cell carcinoma models [313]. The gene discussed is LGALS1; the disease is neoplasm.